MENU
FXH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FXH stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index... Show more

Category: #Health
FXH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FXH with price predictions
Oct 01, 2026

FXH in downward trend: price dove below 50-day moving average on September 30, 2026

FXH moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 36 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for FXH moved out of overbought territory on August 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 29 similar instances where the indicator moved out of overbought territory. In 22 of the 29 cases, the stock moved lower in the following days. This puts the odds of a move lower at 76%.

The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FXH as a result. In 79 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for FXH turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 37 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FXH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +0.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where FXH advanced for three days, in 238 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

FXH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 203 of 257 cases where FXH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 79%.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Merck & Co (NYSE:MRK), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Medtronic plc (NYSE:MDT).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the StrataQuant® Health Care Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is a modified equal-dollar weighted index to objectively identify and select stocks from the Russell 1000® Index in the health care sector that may generate positive alpha relative to traditional passive-style indices through the use of the AlphaDEX® selection methodology.

Market Cap

The average market capitalization across the First Trust Health Care AlphaDEX Fund (FXH) ETF is 70.96B. The market cap for tickers in the group ranges from 3.61B to 1.06T. LLY holds the highest valuation in this group at 1.06T. The lowest valued company is OGN at 3.61B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust Health Care AlphaDEX Fund (FXH) ETF was 14%. For the same ETF, the average monthly price growth was 28%, and the average quarterly price growth was 685%. UTHR experienced the highest price growth at 21%, while BIO experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the First Trust Health Care AlphaDEX Fund (FXH) ETF was -2%. For the same stocks of the ETF, the average monthly volume growth was 13% and the average quarterly volume growth was 11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 46
Price Growth Rating: 47
SMR Rating: 63
Profit Risk Rating: 75
Seasonality Score: 18 (-100 ... +100)
View a ticker or compare two or three
FXH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Category
Health
Address
First Trust Exchange-Traded Alphadex Fd120 East Liberty Drive, Suite 400Wheaton
Phone
N/A
Web
www.ftportfolios.com